The data on which is based the declaration of international emergency for the Zika virus are striking for the lack of evidence to motivate such a pompous statement by the World Health Organization (WHO) in the face of a mild illness, with very little evidence of connection with more serious ailments and without scientific proof.
Zero net emissions: not net, not zero
Since August 1st, the news is spreading that Monsanto had to abandon the construction of one of the biggest factories in the world for producing transgenic seed that was to be installed in Córdoba, Argentina, in the municipality of Malvinas Argentinas. From there they had planned to distribute seeds to Latin America and beyond. This is an occurrence of enormous importance, that the company has not wanted to admit publicly, because the reason for their exit is the persistent popular resistance from neighbourhoods, youths and mothers, who have blocked the factory since 2013.
‘Gene drives’ seem to be the ultimate high-leverage technology. Yesterday’s report from the US National Academies begun the job of describing what is at stake, but it missed some important questions.
Jim Thomas is programme director at the ETC Group
By Silvia Ribeiro
Por Silvia Ribeiro
Aumenta el caos climático, con tormentas feroces fuera de tiempo y lugar, inundaciones donde no las había, sequías interminables, olas de frío o calor extremo, todo con impactos terribles para la gente común y peores para los más vulnerables.
In February 2015, the U.S. National Academy of Sciences along with other institutions published two reports on geoengineering (technological proposals to manipulate the climate) that were funded by, among others, the CIA.
Yesterday, ETC Group reported on the scheduled meeting of Brazil's Judicial Commission to rule on the constitutionality of a bill that would allow the planting of Terminator plants (i.e., plants engineered to be sterile in the second generation) in Brazil. While the Judicial Commission did meet, it postponed the discussion on the Terminator bill until next week.
Background: At a recent Synthetic Biology Conference in Cambridge UK, Synthetic Biologist Jay Keasling announced that the consortium he was working with now intend to replace the entire global supply of artemisinin (an anti-malarial compound) with their new synthetic-biology derived version.